Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Ann Ig ; 32(4): 385-394, 2020.
Article in English | MEDLINE | ID: mdl-32744297

ABSTRACT

BACKGROUND: Malnutrition in Intensive Care Unit patients has been associated with worse clinical outcomes such as mortality and length of stay (LOS) in Intensive Care Unit (ICU), and nutritional status of Intensive Care Unit patients in particular seemed to be a significant predictor of mortality. Promptness of clinical nutrition administration is a key of nutritional support whenever volitional intake is unfeasible. Early enteral nutrition is associated with better clinical outcomes (reduced complications, LOS in ICU and in Hospital). The aim of this study is to investigate the nutrition therapy management in a large Academic Hospital, evaluating its effects on mortality and LOS in ICU and in the Hospital. STUDY DESIGN: Data were collected retrospectively from clinical records. Six physicians were trained on the data collection protocol and they reviewed every clinical record of patients included in the survey. METHODS: Data of 426 patients admitted to ICUs between November 2016, 1st and April 2017, 30th were collected. A multivariate logistic adjusted regression, with backward variables selection method, was performed in order to identify predictors of enteral and parenteral nutrition conducted within 48 hours after admission to the ICU. The relation between medical nutrition therapy, mortality and LOS in ICU and in the Hospital were also evaluated. RESULTS: Patients were given prompt parenteral and enteral nutrition in 25.12% and 27.46% of cases, respectively. No association was found between medical nutrition therapy and ICU or hospital mortality. Predictors of early enteral nutrition were type of admission and surgery before admission; early parenteral nutrition predictors were gender, ICU (A vs B), impaired immunity status and Central Venous Catheter presence at admission. CONCLUSIONS: Our study stresses the need of monitoring nutrition prescribing behaviors in acute hospitals in order to better set up tailored interventions to standardize clinicians' practices and to focus on specific training targets.


Subject(s)
Enteral Nutrition/methods , Intensive Care Units , Malnutrition/therapy , Parenteral Nutrition/methods , Academic Medical Centers , Adult , Aged , Aged, 80 and over , Critical Care/methods , Female , Hospital Mortality , Humans , Italy , Length of Stay , Male , Middle Aged , Nutritional Status , Practice Patterns, Physicians'/statistics & numerical data , Retrospective Studies , Surveys and Questionnaires
2.
Clin Exp Rheumatol ; 25(2): 268-74, 2007.
Article in English | MEDLINE | ID: mdl-17543152

ABSTRACT

OBJECTIVE: Prothrombin (PT) is a target for antibodies with lupus anticoagulant (LA) activity, suggesting the possible application of anti-prothrombin antibody (aPT) assays in patients with antiphospholipid syndrome (APS). Different methods - both homemade and commercial - for the detection of aPT are available, but they seem to produce conflicting results. The purpose of this study was to compare the performance of different assays on a set of well-characterized serum samples. PATIENTS AND METHODS: Sera were gathered from 4 FIRMA institutions, and distributed to 15 participating centres. Forty-five samples were from patients positive for LA and/or anticardiolipin antibodies (aCL) with or without APS, and 15 were from rheumatoid arthritis (RA) patients negative for antiphospholipid antibodies. The samples were evaluated for IgG and IgM antibodies using a homemade direct aPT assay (method 1), a homemade phosphatidylserine-dependent aPT assay (aPS/PT, method 2), and two different commercial kits (methods 3 and 4). In addition, a commercial kit for the detection of IgG-A-M aPT (method 5) was used. RESULTS: Inter-laboratory results for the 5 methods were not always comparable when different methods were used. Good inter-assay concordance was found for IgG antibodies evaluated using methods 1, 3, and 4 (Cohen k > 0.4), while the IgM results were discordant between assays. In patients with thrombosis and pregnancy losses, method 5 performed better than the others. CONCLUSION: While aPT and aPS/PT assays could be of interest from a clinical perspective, their routine performance cannot yet be recommended because of problems connected with the reproducibility and interpretation of the results.


Subject(s)
Antibodies, Anti-Idiotypic/blood , Antiphospholipid Syndrome/immunology , Arthritis, Rheumatoid/immunology , Enzyme-Linked Immunosorbent Assay/methods , Prothrombin/immunology , Antiphospholipid Syndrome/blood , Arthritis, Rheumatoid/blood , Female , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Lupus Coagulation Inhibitor/immunology , Reproducibility of Results
3.
J Vasc Access ; 8(2): 129-30, 2007.
Article in English | MEDLINE | ID: mdl-17534802

ABSTRACT

We report a case of a lady affected by autosomal dominant polycystic kidney disease who had been on hemodialyis for 24 years. She has exhausted all options for arterious-venous fistula. The presence of an acquired anatomical abnormality was an obstacle in order to get appropriate blood flow from standard tunnelled femoral catheters. The enlarged right kidney was pushing the inferior vena cava to the left side of the abdomen, and the abnormality was demonstrated by phlebography. Only after placing a cuffed catheter 53 cm long in her left femoral vein we could dialyze efficiently. Venography is mandatory before placing a cuffed catheter especially in uremic patients with long history of access failure, because it saves costs.


Subject(s)
Catheterization, Central Venous/instrumentation , Catheters, Indwelling , Polycystic Kidney, Autosomal Dominant/therapy , Renal Dialysis/methods , Vena Cava, Inferior , Aged , Equipment Design , Female , Femoral Vein/diagnostic imaging , Humans , Phlebography , Polycystic Kidney, Autosomal Dominant/diagnostic imaging , Time Factors , Vena Cava, Inferior/diagnostic imaging
4.
Lupus ; 15(9): 553-61, 2006.
Article in English | MEDLINE | ID: mdl-17080909

ABSTRACT

The objectives of the study were to characterize the production, function and survival of T lymphocytes of children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital complete heart block. The analysis of thymic function, studied by measuring the level of T-cell receptor excision circles, was performed by real time PCR, the composition of T-cell subpopulation was evaluated by flow cytometry and the T-cell diversity was assayed by heteroduplex analysis. T-cell competence was gauged at two functional levels by determining the proliferation and the number of T-cell divisions and by measuring gamma-interferon production after mitogenic stimulation. We observed that the thymic output, distribution of T-cell subsets, thymidine incorporation, number of T-cell divisions, and y-interferon production were comparable to those of age-matched control. On the contrary, heteroduplex analysis demonstrated the presence of both polyclonal and oligoclonal peripheral T-cell repertoires. In conclusion, the analysis of the T-cell compartment in children with prolonged intrauterine exposure to high dose dexamethasone did not disclose any relevant abnormality, except a restriction of T-cell receptor diversity in some patients.


Subject(s)
Antibodies, Antinuclear/drug effects , Autoantigens/drug effects , Dexamethasone/therapeutic use , Heart Block/drug therapy , Heart Block/immunology , RNA, Small Cytoplasmic/drug effects , Ribonucleoproteins/drug effects , T-Lymphocytes/drug effects , Thymus Gland/drug effects , Antibodies, Antinuclear/immunology , Antigens, CD/drug effects , Antigens, CD/metabolism , Autoantigens/immunology , Case-Control Studies , Cell Compartmentation/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Child , Child, Preschool , Female , Flow Cytometry , Glucocorticoids/therapeutic use , Heart Block/congenital , Heteroduplex Analysis , Humans , Immunophenotyping , Interferon-gamma/biosynthesis , Interferon-gamma/drug effects , Male , Mitogens/pharmacology , Phytohemagglutinins/pharmacology , Polymerase Chain Reaction , RNA, Small Cytoplasmic/immunology , Receptors, Antigen, T-Cell/drug effects , Receptors, Antigen, T-Cell/metabolism , Ribonucleoproteins/immunology , T-Lymphocytes/metabolism , Thymus Gland/cytology , Thymus Gland/metabolism , Treatment Outcome
5.
Clin Exp Rheumatol ; 24(1 Suppl 40): S46-51, 2006.
Article in English | MEDLINE | ID: mdl-16466624

ABSTRACT

Antiphospholipid antibody syndrome is characterized by venous and/or arterial thrombosis and/or pregnancy morbidity associated with antiphospholipid antibodies (aPL), such as anticardiolipin antibodies, anti beta 2 glycoprotein I antibodies and positive lupus anticoagulant test. This syndrome may potentially affects any organ system including the skin. Livedo reticularis is the most frequently observed cutaneous lesion; other lesions, by order of frequency, are ulcerations, digital gangrene, subungueal splinter hemorrhages, superficial venous thrombosis, thrombocytopenic purpura, pseudovasculitic manifestations, extensive cutaneous necrosis and primary anetoderma. Skin lesions are more frequently observed in the catastrophic antiphospholipid syndrome, characterized by widespread microvascular occlusions involving multiple organs simultaneously. Patients with antiphospholipid associated thrombosis should receive long-term oral anticoagulants. The intensity of anticoagulation should be guided according to the nature of the thrombotic event (venous vs. arterial thrombosis). Patients with aPL-associated pregnancy morbidity should be treated with aspirin plus heparin and closely monitored during pregnancy. The treatment of the catastrophic antiphospholipid syndrome remains unsatisfactory. High dose intravenous steroids and parenteral anticoagulation should be supplemented by intravenous gammaglobulin and repeated plasma exchanges using fresh frozen plasma early on in the course of the syndrome.


Subject(s)
Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/diagnosis , Antiphospholipid Syndrome/drug therapy , Skin Diseases/etiology , Female , Humans , Pregnancy , Skin Diseases, Vascular/etiology , Thrombosis/etiology
6.
AIDS Res Hum Retroviruses ; 16(17): 1805-7, 2000 Nov 20.
Article in English | MEDLINE | ID: mdl-11118066

ABSTRACT

The mechanism causing the increasing number of peripheral T cells after highly active antiretroviral therapy (HAART) is still unclear. The bcl-2 oncogene prevents spontaneous apoptosis (SA) in lymphocytes. Spontaneous apoptosis could be a determinant of HIV immunodeficiency and can be reversed by HAART including protease inhibitors (PI-HAART). The aims of our study were to measure Bcl-2 protein expression in memory (CD45RO+) and naive (CD45RO-) CD4+ and CD8+ T lymphocytes of HIV+ patients and to correlate it with efficacy of PI-HAART. Forty-nine HIV+ patients (cases) and 26 HIV- individuals (controls) were evaluated. Patients receiving PI-HAART, and who had undetectable HIV plasma viral load (VL-, n = 21), had higher levels of Bcl-2 than did VL+ patients (n = 28), both in CD4+ cells (p < 0.0001) and in CD8+ cells (p < 0.001). VL+ patients had lower Bcl-2 levels than did controls in CD8+ cells (p = 0.02), but not in CD4+ cells (p > 0.05). Interestingly, VL- patients had higher Bcl-2 expression than did controls both in CD4+ cells (p < 0.0001) and in CD8+ cells (p = 0.03). In a subcohort of the same patients, Bcl-2 was significantly higher in VL- patients (n = 10) than in controls (n = 12), both in naive CD4+ cells (p < 0.0001) and in naive CD8+ cells (p = 0.01). Naive CD4+ cells had higher Bcl-2 expression in VL- than in VL+ patients (p = 0.01). In a subsequent longitudinal study of nine HIV patients, naive CD4+ cells increased after effective PI-HAART (p = 0.03), which paralleled an increase in Bcl-2 expression in the same cells (p = 0.02). In conclusion, upregulation of bcl-2 could be a mechanism of immune reconstitution of naive CD4+ T cells induced by PI-HAART.


Subject(s)
Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active , CD4-Positive T-Lymphocytes/metabolism , HIV Infections/drug therapy , Proto-Oncogene Proteins c-bcl-2/metabolism , Adult , Aged , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Female , HIV Infections/immunology , HIV Infections/virology , HIV-1/physiology , Humans , Male , Middle Aged , Reverse Transcriptase Inhibitors/therapeutic use , Viral Load
7.
Eur J Immunol ; 30(11): 3067-78, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11093121

ABSTRACT

T cells specific for a single viral epitope, but using different T cell receptors, should have flexibility in their epitope recognition to protect the infected host against the emergence of viral escape mutants. Therefore, polyclonality of the hepatitis B virus (HBV)-specific cytotoxic T lymphocyte response has been hypothesized to be a major determinant in the control of infection. We analyzed the Vbeta chain composition of the core 18-27-specific CD8 cells in acute and persistently HBV-infected patients using HLA-A2 tetrameric complexes and a panel of Vbeta antibodies. Different T cell receptors were utilized by core 18-27-specific CD8 cells both in patients with acute and chronic infection. The functional ability of these epitope-specific T cells to respond to potential viral mutations was then tested. The polyclonal HBV-specific CD8 response present in patients with acute hepatitis displayed a limited efficiency to recognize mutations introduced within the epitope. The ability of core 18-27-specific CD8 to tolerate epitope mutations was found only during persistent HBV infection. The data suggest that although a clonally heterogeneous CD8 response can be largely inhibited by the occurrence of single epitope mutations in primary HBV infection, preferential selection of T cells able to counteract the emergence of viral mutations can occur during persistent infection.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Cytotoxicity, Immunologic , Hepatitis B, Chronic/immunology , Hepatitis B/immunology , Receptors, Antigen, T-Cell/immunology , Acute Disease , Adult , Antigens, Viral/genetics , Antigens, Viral/immunology , Epitopes/immunology , Humans , Mutation
8.
Clin Immunol ; 96(1): 67-75, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10873429

ABSTRACT

A population of Vdelta1(+)Vgamma9(-) gammadelta T cells that represented almost the totality (84%) of circulating lymphocytes in a patient with chronic, non-HIV-related, CD4 lymphocytopenia complicated by a disseminated Mycobacterium intracellulare infection was characterized. These gammadelta(+) T cells expressed a single killer inhibitory receptor (CD158b) and their phenotype (CD8(+)CD57(+)CD27(-)CD28(-)) indicated that, although CD45RA(+), they were not naive. However, the absence of large granular lymphocyte morphology, the impaired proliferative activity, the high susceptibility to apoptosis, and the total lack of cytotoxic ability suggested that these gammadelta cells were in a resting state. A high percentage of the cells did not harbor the CD11b integrin alpha chain and exhibited a decreased capability to bind endothelial cells. This defect might represent the mechanism whereby they remained trapped in the circulation.


Subject(s)
Killer Cells, Natural/immunology , Mycobacterium avium-intracellulare Infection/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology , Receptors, Immunologic/biosynthesis , T-Lymphocytopenia, Idiopathic CD4-Positive/immunology , Antigens, CD/classification , Apoptosis/immunology , CD28 Antigens/immunology , CD8 Antigens/immunology , Cell Adhesion , Cell Division , Chronic Disease , Cytotoxicity, Immunologic/immunology , Endothelium, Vascular/cytology , Female , Humans , Immunophenotyping , Macrophage-1 Antigen/immunology , Middle Aged , Mycobacterium avium Complex/immunology , Mycobacterium avium-intracellulare Infection/blood , Mycobacterium avium-intracellulare Infection/complications , Receptors, Immunologic/immunology , Receptors, KIR , Receptors, KIR2DL3 , T-Lymphocytopenia, Idiopathic CD4-Positive/blood , T-Lymphocytopenia, Idiopathic CD4-Positive/complications
9.
Circulation ; 100(19): 1983-91, 1999 Nov 09.
Article in English | MEDLINE | ID: mdl-10556225

ABSTRACT

BACKGROUND: Cytokine activation and endothelial dysfunction are typical phenomena of congestive heart failure (CHF). We tested the hypothesis that incubating human umbilical vein endothelial cells with serum from patients with CHF will downregulate endothelial constitutive nitric oxide synthase (eNOS) and induce apoptosis. METHODS AND RESULTS: We studied 21 patients with severe CHF. Levels of tumor necrosis factor-alpha (TNF-alpha) and several neuroendocrine parameters were assessed. eNOS was measured by Western Blot analysis and apoptosis by optical microscopy and flow cytometry. We observed (1) eNOS downregulation (difference versus healthy subjects at 24 hours [P<0.05] and 48 hours [P<0.001]), (2) nuclear morphological changes typical of apoptosis; and (3) a high apoptotic rate with propidium iodide (increasing from 2.1+/-0.4% to 11.3+/-1.2% at 48 hours; P<0.001 versus healthy subjects) and annexin V. An anti-human TNF-alpha antibody did not completely counteract these effects. A strong correlation existed between eNOS downregulation and apoptosis (r = -0.89; P<0.001). CONCLUSIONS: Serum from patients with severe CHF downregulates eNOS expression and increases apoptosis. High levels of TNF-alpha likely play a role, but they cannot be the only factor responsible.


Subject(s)
Apoptosis , Heart Failure/blood , Nitric Oxide Synthase/antagonists & inhibitors , Tumor Necrosis Factor-alpha/physiology , Aged , Cells, Cultured , Down-Regulation , Endothelium, Vascular/physiology , Flow Cytometry , Humans , Middle Aged , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type III
10.
J Leukoc Biol ; 65(5): 641-8, 1999 May.
Article in English | MEDLINE | ID: mdl-10331493

ABSTRACT

According to CD28 molecule expression, CD8+ T cells can be classed as CD28bright, CD28dim, and CD28-. The CD28dim T cells were found to derive from mitogenic stimulated CD28-T cells but also from CD28bright T cells through a mechanism of CD28 down-modulation. Moreover, after prolonged in vitro interleukin-2 stimulation, clonal CD28bright, cells showed a CD28dim expression before further evolution to a stable CD28-phenotype. This loss was concomitant with the disappearance of CD28 mRNA. A study of the cytokine production pattern revealed that CD28dim and CD28- T cell clones produced similar levels of type 1 and type 2 cytokines, which differed from those produced by the CD28bright T cell clones. A high percentage of CD28dim and CD28- cells, with similarities in their cytokine production pattern, were found in the blood samples of HIV-infected patients, as compared to healthy donors. The CD28 down-modulation may account for the increased number of CD8+CD28- T cells in HIV-infected patients.


Subject(s)
CD28 Antigens/biosynthesis , CD8-Positive T-Lymphocytes/immunology , HIV Infections/immunology , HIV-1/immunology , Lymphocyte Activation/immunology , T-Lymphocyte Subsets/immunology , Adult , CD28 Antigens/immunology , CD8-Positive T-Lymphocytes/metabolism , Clone Cells , Female , Humans , Immunophenotyping , Interferon-gamma/metabolism , Interleukins/metabolism , Male , T-Lymphocyte Subsets/metabolism
11.
Eur J Immunol ; 28(11): 3630-8, 1998 11.
Article in English | MEDLINE | ID: mdl-9842905

ABSTRACT

T cell clones are classified as type 0, 1 or 2 depending on the lymphokines they produce. However, it has remained unclear whether single cells of a given type produce one or several cytokine species. Flow cytometric analysis of peripheral blood lymphocytes (PBL) obtained from 20 healthy donors for the production of the type 1 cytokines IFN-gamma and IL-2 revealed very few cells that co-expressed both cytokines independently of the mitogenic stimulus used for PBL activation. Similarly, kinetic studies of cytokine synthesis indicated a low percentage of IFN-gamma/IL-2 double-positive T cells at all time points. Reverse transcription-PCR analysis of sorted IL-2- and IFN-gamma-positive T cells showed the presence of IL-2- or IFN-gamma-specific mRNA only in those cells expressing the corresponding cytokine. This segregation of the two type 1 cytokines was lost in long-term cultured T cells and in T cell clones. A high percentage of cells expressing only IL-2 or IFN-gamma was observed even when the production of these cytokines was evaluated on CD4- and CD8+ subsets. Moreover, in some healthy individuals, IFN-gamma and IL-2 production by CD8+ T cells was related to CD8+ expression levels and cell size, i. e. IL-2-expressing cells were generally smaller with more intense CD8+ staining as compared with IFN-gamma-producing T cells. These data indicate that activated T lymphocytes are strongly committed in vivo to produce IFN-gamma or IL-2 and emphasizes the independent regulation of the two cytokine genes.


Subject(s)
CD8-Positive T-Lymphocytes/metabolism , Interferon-gamma/biosynthesis , Interleukin-2/biosynthesis , Cells, Cultured , Humans , Immunophenotyping , Interferon-gamma/genetics , Interleukin-2/genetics , RNA, Messenger/analysis
13.
J Immunol ; 161(2): 1026-33, 1998 Jul 15.
Article in English | MEDLINE | ID: mdl-9670984

ABSTRACT

Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by trombocytopenia, eczema, and progressive decline of the immune function. In addition, lymphocytes and platelets from WAS patients have morphologic abnormalities. Since chemokines may induce morphologic changes and migration of leukocytes, we investigated the monocyte response to chemoattractants in cells from WAS patients with an identified mutation in the WAS protein gene. Here, we report that monocytes derived from four patients with molecularly defined typical WAS have a severely impaired migration in response to FMLP and to the chemokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha compared with normal donors. Conversely, neither MCP-1 binding to monocytes nor induction of the respiratory burst by MCP-1 and FMLP is significantly different between WAS patients and normal donors. Within a few minutes of stimulation, monocytes respond to chemokines with increased expression of adhesion molecules and with morphologic changes such as cell polarization. Although up-regulation of CD11b/CD18 expression following stimulation with FMLP or MCP-1 is preserved in WAS patients, cell polarization is dramatically decreased. Staining of F-actin by FITC-phalloidin in monocytes stimulated with chemoattractants shows F-actin to have a rounded shape in WAS patients, as opposed to the polymorphic distribution of F-actin in the polarized monocytes from healthy donors. These results suggest that WAS protein is involved in the monocyte response to the chemokines MCP-1 and macrophage inflammatory protein-1alpha.


Subject(s)
Cell Polarity/immunology , Chemokine CCL2/pharmacology , Chemotaxis, Leukocyte/immunology , Monocytes/immunology , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Wiskott-Aldrich Syndrome/immunology , Cell Movement/drug effects , Cell Movement/immunology , Cell Polarity/drug effects , Cell Size/drug effects , Cell Size/immunology , Chemokine CCL2/blood , Chemokine CCL2/metabolism , Chemotaxis, Leukocyte/drug effects , Child, Preschool , Humans , Infant , Monocytes/metabolism , Protein Binding/immunology
14.
J Clin Invest ; 101(1): 137-44, 1998 Jan 01.
Article in English | MEDLINE | ID: mdl-9421475

ABSTRACT

The relationship between the number of circulating CD4+ T cells and the presence of particular CD8+ T cell subsets was analyzed by flow cytometry on PBL from asymptomatic HIV-1-infected patients whose specimens were collected every 2 mo for a total period of 32 mo. Only slight variations were detected in the absolute number of lymphocytes and percentage of CD3+ lymphocytes, whereas both CD4+ and CD8+ T cell subsets showed wide intrapatient variation. Variations in the number of CD8+CD28+ cells paralleled those of the CD4+ T cell subset in each patient tested, while the presence of CD8+CD28- T cells correlated inversely with CD4+ and CD8+CD28+ T cells. These data show that changes in the number of circulating CD4+-and CD8+CD28+ T cells are strongly related to the presence of CD8+CD28- T cells in these patients. Insight into the significance of CD8+CD28- T cell expansion will allow us to understand the mechanisms and significance of the HIV-1- driven change in CD4+CD8+ T cell homeostasis and the basic immunopathology of HIV disease.


Subject(s)
CD28 Antigens/immunology , CD3 Complex/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , HIV Infections/immunology , HIV-1/immunology , T-Lymphocytes/immunology , Female , Homeostasis , Humans , Lymphocyte Count , Male , T-Lymphocytes/cytology
15.
AIDS Res Hum Retroviruses ; 13(17): 1501-8, 1997 Nov 20.
Article in English | MEDLINE | ID: mdl-9390749

ABSTRACT

In vitro spontaneous apoptosis (SA) of lymphocytes was studied in HIV infection to evaluate possible clinical and prognostic correlations, in a transsectional study of 101 individuals in different clinical categories and in a prospective longitudinal study of 18 asymptomatic individuals (mean follow-up, 17.2 months). The rate of SA was higher in HIV+ patients than in healthy controls (p < 0.001) and was higher in patients with AIDS than in the other HIV+ individuals (p < 0.001). It was inversely correlated with the peripheral blood CD4+ (R -0.61; p < 0.001) and CD8+ (R -0.46; p < 0.001) cell numbers. In a group of long-term survivors (LTS), it was significantly lower than in a control group of asymptomatic HIV+ patients with a similar number of circulating CD4+ lymphocytes but a shorter follow-up (p < 0.02). In the five asymptomatic HIV-infected individuals who showed a clinical progression, peaks of SA rates above the normal range before the clinical event were much more frequent than in those who remained asymptomatic (p < 0.0001), even though they were fairly homogeneous as far as CD4+ cell count and viral load were concerned. The median levels of SA rates were moreover correlated with the rate of total T cell loss (R -0.46; p 0.053). This study suggests that evaluation of the SA levels may provide a predictive factor for clinical and immunological progression of HIV-related immunodeficiencies and strengthen the hypothesis for the role of this phenomenon in the pathogenesis of this progression.


Subject(s)
Apoptosis , HIV Infections/pathology , Adult , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/cytology , Cross-Sectional Studies , Female , Humans , Longitudinal Studies , Lymphocyte Depletion , Male , Middle Aged , Prospective Studies , Survivors , Viral Load
16.
Clin Exp Immunol ; 109(3): 412-5, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9328114

ABSTRACT

To evaluate whether vertical HIV infection interferes with the expression of CD28 on T lymphocytes, 25 HIV-infected children and 29 seroreverted children born to HIV+ mothers were studied. The percentage of CD28- cells among CD8+ T lymphocytes was higher in HIV-infected children than in controls (P < 0.001). In fact, in HIV-infected children, this percentage was elevated from the first year of life, while in healthy seroreverted children, the proportion of CD28- cells among CD8+ cells rose progressively with age (r = 0.49; P = 0.008). In HIV+ children, the CD8+ CD28-, but not CD8+ CD28+ cell proportion was significantly correlated with immunological markers of disease progression, such as CD4+ cell loss (r = -0.65; P < 0.001) and the level of in vitro spontaneous lymphocyte apoptosis (r = 0.53; P = 0.03).


Subject(s)
CD28 Antigens/immunology , CD8-Positive T-Lymphocytes/immunology , HIV Infections/immunology , HIV Infections/transmission , Age Factors , Apoptosis , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/immunology , Child , Child, Preschool , HIV Seropositivity , Humans , Infant , Infectious Disease Transmission, Vertical , Lymphocyte Count
17.
Pediatr Allergy Immunol ; 7(4): 176-9, 1996 Nov.
Article in English | MEDLINE | ID: mdl-9151338

ABSTRACT

BACKGROUND: Common Variable Immunodeficiency (CVID) is characterized by defective antibody production. This has been variably attributed to intrinsic B-cell defects or to T-cell disfunctions. Recently, it has been reported that the expression of the CD40 Ligand (CD40L), a T-cell surface molecule that plays a critical role in the cell-contact-mediated helper signals provided to B-cells, is defective in a subset of patients with CVID. METHODS: To demonstrate that the defective expression is due to intrinsic functional abnormalities of CD4+ lymphocytes, CD4+ cells were purified from eight patients with CVID and eight age-paired controls, stimulated with PMA+Ionomycin, and studied for CD40L expression by flow cytometry using specific monoclonal antibodies. RESULTS AND CONCLUSIONS: The percentage of CD4+ cells expressing CD40L after optimal stimulation was correlated with age both in patients with CVID (r: 0.74; p: 0.04) and in healthy controls (r: 0.73; p: 0.04). The percentage of CD40L+ cells was reduced in patients with CVID compared to that of controls (p: 0.02 when data are paired for age) with a reduced density of expression (p: < 0.01). The defect was variable in different patients and in some cases it was marginal.


Subject(s)
CD4-Positive T-Lymphocytes/chemistry , Common Variable Immunodeficiency/immunology , Lymphocyte Activation , Membrane Glycoproteins/analysis , Adolescent , Adult , Age Factors , CD40 Ligand , Child , Female , Humans , Male
19.
Immunol Lett ; 49(1-2): 27-30, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8964605

ABSTRACT

The CD40 ligand (CD40L) is a molecule expressed by activated T cells which plays a critical role in the regulation of B-cell responses, including differentiation into Ig-producing cells. Using the specific monoclonal antibody TRAP1 we have evaluated the ontogeny of CD40L expression in 97 normal individuals between birth and 50 years of age. The expression of CD40L is a function of age; it is severely reduced at birth, progressively increases during the first months of life, and reaches a plateau in the second decade. This progressive attainment of the ability to express CD40L is due to a process of maturation of the CD4 + subset, being significantly correlated with the expression of the CD45RO antigen.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , Lymphocyte Activation , Membrane Glycoproteins/biosynthesis , Adolescent , Adult , Age Factors , Antibodies, Monoclonal/immunology , CD40 Ligand , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Leukocyte Common Antigens/biosynthesis , Membrane Glycoproteins/immunology , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...